SC
BIO icon

Sierra Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Sierra Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-29
Closed -$12K – 229
2022
Q4 		$12K Hold
29
– – ﹤0.01% 339
2022
Q3 		$12K Hold
29
– – ﹤0.01% 353
2022
Q2 		$14K Hold
29
– – ﹤0.01% 419
2022
Q1 		$16K Hold
29
– – ﹤0.01% 427
2021
Q4 		$22K Hold
29
– – ﹤0.01% 401
2021
Q3 		$22K Sell
29
-7
-19% -$5.24K ﹤0.01% 342
2021
Q2 		$23K Hold
36
– – ﹤0.01% 324
2021
Q1 		$21K Buy
+36
New +$21.3K ﹤0.01% 310

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sierra Capital's BIO Position: Q1 2023 in Review

Sierra Capital sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2023, closing a stake of 29 shares — an estimated $12K sold.

Sierra Capital first reported a position in BIO in Q1 2021 and held it in 8 quarters. The position peaked at $23K in Q2 2021. 504 funds tracked by Wall St. Rank hold BIO as of Q1 2023.

  • Sierra Capital reported no remaining Bio-Rad Laboratories Class A position as of Q1 2023 after selling out during the quarter.
  • Sierra Capital sold 29 Bio-Rad Laboratories Class A shares in Q1 2023, an estimated $12K.
  • Sierra Capital first reported a position in Bio-Rad Laboratories Class A in Q1 2021 and held it in 8 quarters.
  • Sierra Capital's Bio-Rad Laboratories Class A position peaked at $23K in Q2 2021.
  • 504 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2023.

Based on Sierra Capital's 13F filing for Q1 2023, filed 1 May 2023.